News · 26 weeks121+300%
2026-03-012026-08-23
Mix6090d
- Insider40(67%)
- Other12(20%)
- SEC Filings6(10%)
- Earnings2(3%)
Latest news
25 items- INSIDERChief Policy Officer Autor Deborah M. sold $467,128 worth of shares (16,773 units at $27.85) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 48,961 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Financial Officer Okupe Oluyemi sold $148,111 worth of shares (4,938 units at $29.99) as part of a pre-agreed trading plan and exercised 4,938 shares at a strike of $5.01 (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil sold $691,808 worth of shares (25,111 units at $27.55) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 313,964 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 21,500 shares, increasing direct ownership by 7% to 339,075 units (SEC Form 4) to satisfy tax liability4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Medical Officer Carroll Patrick Harrison converted options into 26,187 shares and covered exercise/tax liability with 10,201 shares, increasing direct ownership by 9% to 197,847 units (SEC Form 4) (for tax liability)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Schultz Kare converted options into 6,623 shares, increasing direct ownership by 34% to 26,020 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Policy Officer Autor Deborah M. converted options into 32,920 shares and covered exercise/tax liability with 16,147 shares, increasing direct ownership by 34% to 65,734 units (SEC Form 4) to satisfy withholding tax4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERCTO Elshenawy Mohamed converted options into 188,285 shares and covered exercise/tax liability with 95,798 shares, increasing direct ownership by 92% to 193,510 units (SEC Form 4) (tax withholding)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Operating Officer Chi Michael converted options into 86,265 shares and covered exercise/tax liability with 47,702 shares, increasing direct ownership by 9% to 470,687 units (SEC Form 4) to satisfy withholding obligation4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Executive Officer Dudum Andrew converted options into 154,993 shares and covered exercise/tax liability with 78,859 shares, increasing direct ownership by 8% to 1,033,177 units (SEC Form 4) to satisfy withholding obligation4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Payne Christopher D converted options into 545 shares, increasing direct ownership by 2% to 34,863 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERDirector Wells David B converted options into 778 shares, increasing direct ownership by 0.34% to 229,808 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERPAO Becklund Irene converted options into 13,685 shares and covered exercise/tax liability with 6,490 shares, increasing direct ownership by 106% to 13,985 units (SEC Form 4) to satisfy tax liability4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Financial Officer Okupe Oluyemi sold $2,205,192 worth of shares (64,771 units at $34.05) as part of a pre-agreed trading plan, exercised 81,004 shares at a strike of $0.58 and covered exercise/tax liability with 36,437 shares, decreasing direct ownership by 7% to 264,117 units (SEC Form 4) (for tax liability)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- PRUniphore Launches Marketing AI to Usher in New Era: NYSE Content UpdateNYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Aug. 17, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on August 17thUniphore Co-founder & CEO Umesh Sachdev to discuss latest offering.Marketing AI is built on customer intelligence rather than customer data management.The company says the solution can predict what each customer is likely to do next.The S&P 500 looks to build on a three-week win streak. Retail earnings and Wednesday's
- INSIDERSEC Form 4 filed by Director Perez Garcia Andrea G4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Director Payne Christopher D4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by Director Schultz Kare4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 4 filed by CTO Elshenawy Mohamed4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- PRBerger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)PHILADELPHIA, Aug. 12, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE:HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation is focused on whether the Company improperly shared private user health data with advertisers, engaged in deceptive billing practices, and made subscription cancellations unnecessarily difficult. Hims & Hers, headquartered in San Francisco, Calif., is a digital health platform that connects individuals with li
- SECSEC Form 10-Q filed by Hims & Hers Health Inc.10-Q - Hims & Hers Health, Inc. (0001773751) (Filer)
- SECHims & Hers Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Hims & Hers Health, Inc. (0001773751) (Filer)
- PRHims & Hers Health, Inc. Reports Second Quarter 2026 Financial ResultsRevenue of approximately $753 million, up 38% year-over-year in Q2 2026 Subscribers grew to nearly 2.9 million, up 19% year-over-year in Q2 2026 Raises full year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion and updates Adjusted EBITDA guidance to a range of $275 million to $325 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading global health and wellness platform, today announced financial results for the second quarter ended June 30, 2026. "Hims & Hers is delivering a world-class health experience at a global scale and a reasonable price for the nearly 3 million people who rely on us for access to care. We’re proving, qua
- PRHims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care ExperienceRebuilt from the ground up, the new Hers app puts women in one continuous conversation with their providers, Care Teams, and AI, delivering personalized weight loss support the moment she needs it Hims & Hers, the leading health and wellness platform, today announced a first-of-its-kind* intelligent care experience that puts AI directly inside customers’ care, not on the sidelines of it. Rolling out first to Hers weight loss members, this proactive care experience delivers personalized guidance, real-time attention to her progress, and keeps her motivated so she can hit her goals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2
- PRHims & Hers Responds to FTC LawsuitHims & Hers Health, Inc. (NYSE:HIMS) responded to the lawsuit filed today by the Federal Trade Commission (FTC): This lawsuit disregards substantial evidence we provided the FTC during its nearly three-year investigation, ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims. This is not enforcement grounded in consumer protection; it is an effort to generate headlines at our expense. We are confident in our position and will vigorously defend ourselves against these baseless claims. We’ve long shared the goal of the FTC’s new Healthcare Task Force to create a more competitive, innovative, affordable, and higher-quality he
HIMS FAQ
7 questionsWhat does Hims & Hers Health Inc. do?
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin...Where does HIMS stock trade?
Hims & Hers Health Inc. (HIMS) is listed on NYSE.What sector and industry is HIMS in?
Hims & Hers Health Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did Hims & Hers Health Inc. go public?
Hims & Hers Health Inc. (HIMS) completed its IPO in 2019.What are analysts saying about HIMS?
Hims & Hers Health Inc. has had 8 recent analyst actions on file. The most recent action was from Needham: Buy with a $3500.00 price target on 2026-05-12. Recent price targets range from $2300.00 to $4800.00.What companies are similar to HIMS?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), CHE (Chemed Corp), LFST (LifeStance Health Group Inc.), AMED (Amedisys Inc), LHCG (LHC Group). Compare HIMS side-by-side with any of them on Quantisnow.How can I track HIMS on Quantisnow?
Quantisnow aggregates Hims & Hers Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HIMS to receive live email and push alerts on every new disclosure.